Terlipressin CAS NO.14636-12-5

product name

terlipressin acetate

equence

n-(n-(n-glycylglycyl)glycyl)-8-l-lysinevasopressin; (2s)-1-[(4s,7s,10s,13s,16s,19s)-19-[[2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetyl]amino]-13-benzyl-10-(2-carbamoylethyl)-7-(carbamoylmethyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-n-[(1s)-5-amino-1-(carbamoylmethylcarbamoyl)pentyl]pyrrolidine-2-carboxamide; (2s)-1-{[(4r,7s,10s,13s,16s,19r)-19-{[({[(aminoacetyl)amino]acetyl}amino)acetyl]amino}-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}-n-{(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl}pyrrolidine-2-carboxamide (non-preferred name)

cas no.

14636-12-5

molecular formula

c52h74n16o15s2

molecular weight

1227.37

purity (hplc)

98.0%min.

appearance

white powder

single impurity (hplc)

1.0%max

amino acid composition

±10% of theoretical

peptide content (n%)

≥80.0%

water content(karl fischer)

≤10.0%

specific rotation (20/d)

-95.0～-105.0°(c=1 1%hac)

acetate content (hpic)

≤15.0%

ms(esi)

consistent

mass balance

95.0~105.0%